Insider Trading & Ownership of LYONS GARY A

Location: San Diego, CA
Summary: The estimated value of insider holdings of LYONS GARY A is at least $20.2M dollars as of 04 Dec 2025. LYONS GARY A is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $18.4M. LYONS GARY A is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.05M. LYONS GARY A is the Director of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $674K. LYONS GARY A is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $131K.
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when LYONS GARY A files a new Insider Trading report.

Ownership of LYONS GARY A

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NBIX	NEUROCRINE BIOSCIENCES INC	Director	$18.4M	-$2.29M	-11.1%	03 Dec 2025
TVTX	Travere Therapeutics, Inc.	Director	$1.05M			15 May 2025
ELDN	Eledon Pharmaceuticals, Inc.	Director	$674K			01 May 2023
RIGL	RIGEL PHARMACEUTICALS INC	Director	$131K			26 May 2023
FRTX	Fresh Tracks Therapeutics, Inc.	Director				17 May 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.